世界の老年医療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Geriatric Medicine Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z2559 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥565,500 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥848,250 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,131,000 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、老年医療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬）、用途別市場規模（心臓血管、関節炎、神経、癌、骨粗鬆症、呼吸器）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・老年医療の市場動向 ・企業の競争状況、市場シェア ・老年医療の種類別市場規模（鎮痛薬、降圧薬、スタチン、抗糖尿病薬、プロトンポンプ阻害薬、抗凝固薬、抗精神病薬、抗うつ薬） ・老年医療の用途別市場規模（心臓血管、関節炎、神経、癌、骨粗鬆症、呼吸器） ・老年医療の北米市場規模2016-2027（アメリカ、カナダ） ・老年医療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・老年医療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・老年医療の中南米市場規模2016-2027（メキシコ、ブラジル） ・老年医療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（GSK、Boehringer Ingelheim、Novartis、Bristol-Myers Squibb、Pfizer、Eli Lilly、Abbott、AstraZeneca、Merck、Sanofi S.A.） ・結論

Market Analysis and Insights: Global Geriatric Medicine Market
The global Geriatric Medicine market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Geriatric Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Geriatric Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Geriatric Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Geriatric Medicine market.

Global Geriatric Medicine Scope and Market Size
Geriatric Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Geriatric Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Analgesics
Antihypertensives
Statins
Antidiabetics
Proton Pump Inhibitor
Anticoagulant
Antipsychotic
Antidepressant

Segment by Application
Cardiovascular
Arthritis
Neurological
Cancer
Osteoporosis
Respiratory

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
GSK
Boehringer Ingelheim
Novartis
Bristol-Myers Squibb
Pfizer
Eli Lilly
Abbott
AstraZeneca
Merck

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Geriatric Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Analgesics
1.2.3 Antihypertensives
1.2.4 Statins
1.2.5 Antidiabetics
1.2.6 Proton Pump Inhibitor
1.2.7 Anticoagulant
1.2.8 Antipsychotic
1.2.9 Antidepressant
1.3 Market by Application
1.3.1 Global Geriatric Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Cardiovascular
1.3.3 Arthritis
1.3.4 Neurological
1.3.5 Cancer
1.3.6 Osteoporosis
1.3.7 Respiratory
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Geriatric Medicine Market Perspective (2016-2027)
2.2 Geriatric Medicine Growth Trends by Regions
2.2.1 Geriatric Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Geriatric Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Geriatric Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Geriatric Medicine Industry Dynamic
2.3.1 Geriatric Medicine Market Trends
2.3.2 Geriatric Medicine Market Drivers
2.3.3 Geriatric Medicine Market Challenges
2.3.4 Geriatric Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Geriatric Medicine Players by Revenue
3.1.1 Global Top Geriatric Medicine Players by Revenue (2016-2021)
3.1.2 Global Geriatric Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Geriatric Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Geriatric Medicine Revenue
3.4 Global Geriatric Medicine Market Concentration Ratio
3.4.1 Global Geriatric Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Geriatric Medicine Revenue in 2020
3.5 Geriatric Medicine Key Players Head office and Area Served
3.6 Key Players Geriatric Medicine Product Solution and Service
3.7 Date of Enter into Geriatric Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Geriatric Medicine Breakdown Data by Type
4.1 Global Geriatric Medicine Historic Market Size by Type (2016-2021)
4.2 Global Geriatric Medicine Forecasted Market Size by Type (2022-2027)

5 Geriatric Medicine Breakdown Data by Application
5.1 Global Geriatric Medicine Historic Market Size by Application (2016-2021)
5.2 Global Geriatric Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Geriatric Medicine Market Size (2016-2027)
6.2 North America Geriatric Medicine Market Size by Type
6.2.1 North America Geriatric Medicine Market Size by Type (2016-2021)
6.2.2 North America Geriatric Medicine Market Size by Type (2022-2027)
6.2.3 North America Geriatric Medicine Market Size by Type (2016-2027)
6.3 North America Geriatric Medicine Market Size by Application
6.3.1 North America Geriatric Medicine Market Size by Application (2016-2021)
6.3.2 North America Geriatric Medicine Market Size by Application (2022-2027)
6.3.3 North America Geriatric Medicine Market Size by Application (2016-2027)
6.4 North America Geriatric Medicine Market Size by Country
6.4.1 North America Geriatric Medicine Market Size by Country (2016-2021)
6.4.2 North America Geriatric Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Geriatric Medicine Market Size (2016-2027)
7.2 Europe Geriatric Medicine Market Size by Type
7.2.1 Europe Geriatric Medicine Market Size by Type (2016-2021)
7.2.2 Europe Geriatric Medicine Market Size by Type (2022-2027)
7.2.3 Europe Geriatric Medicine Market Size by Type (2016-2027)
7.3 Europe Geriatric Medicine Market Size by Application
7.3.1 Europe Geriatric Medicine Market Size by Application (2016-2021)
7.3.2 Europe Geriatric Medicine Market Size by Application (2022-2027)
7.3.3 Europe Geriatric Medicine Market Size by Application (2016-2027)
7.4 Europe Geriatric Medicine Market Size by Country
7.4.1 Europe Geriatric Medicine Market Size by Country (2016-2021)
7.4.2 Europe Geriatric Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Geriatric Medicine Market Size (2016-2027)
8.2 Asia-Pacific Geriatric Medicine Market Size by Type
8.2.1 Asia-Pacific Geriatric Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Geriatric Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Geriatric Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Geriatric Medicine Market Size by Application
8.3.1 Asia-Pacific Geriatric Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Geriatric Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Geriatric Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Geriatric Medicine Market Size by Region
8.4.1 Asia-Pacific Geriatric Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Geriatric Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Geriatric Medicine Market Size (2016-2027)
9.2 Latin America Geriatric Medicine Market Size by Type
9.2.1 Latin America Geriatric Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Geriatric Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Geriatric Medicine Market Size by Type (2016-2027)
9.3 Latin America Geriatric Medicine Market Size by Application
9.3.1 Latin America Geriatric Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Geriatric Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Geriatric Medicine Market Size by Application (2016-2027)
9.4 Latin America Geriatric Medicine Market Size by Country
9.4.1 Latin America Geriatric Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Geriatric Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Geriatric Medicine Market Size (2016-2027)
10.2 Middle East & Africa Geriatric Medicine Market Size by Type
10.2.1 Middle East & Africa Geriatric Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Geriatric Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Geriatric Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Geriatric Medicine Market Size by Application
10.3.1 Middle East & Africa Geriatric Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Geriatric Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Geriatric Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Geriatric Medicine Market Size by Country
10.4.1 Middle East & Africa Geriatric Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Geriatric Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 GSK
11.1.1 GSK Company Details
11.1.2 GSK Business Overview
11.1.3 GSK Geriatric Medicine Introduction
11.1.4 GSK Revenue in Geriatric Medicine Business (2016-2021)
11.1.5 GSK Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Geriatric Medicine Introduction
11.2.4 Boehringer Ingelheim Revenue in Geriatric Medicine Business (2016-2021)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Novartis Business Overview
11.3.3 Novartis Geriatric Medicine Introduction
11.3.4 Novartis Revenue in Geriatric Medicine Business (2016-2021)
11.3.5 Novartis Recent Development
11.4 Bristol-Myers Squibb
11.4.1 Bristol-Myers Squibb Company Details
11.4.2 Bristol-Myers Squibb Business Overview
11.4.3 Bristol-Myers Squibb Geriatric Medicine Introduction
11.4.4 Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2016-2021)
11.4.5 Bristol-Myers Squibb Recent Development
11.5 Pfizer
11.5.1 Pfizer Company Details
11.5.2 Pfizer Business Overview
11.5.3 Pfizer Geriatric Medicine Introduction
11.5.4 Pfizer Revenue in Geriatric Medicine Business (2016-2021)
11.5.5 Pfizer Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Geriatric Medicine Introduction
11.6.4 Eli Lilly Revenue in Geriatric Medicine Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Abbott
11.7.1 Abbott Company Details
11.7.2 Abbott Business Overview
11.7.3 Abbott Geriatric Medicine Introduction
11.7.4 Abbott Revenue in Geriatric Medicine Business (2016-2021)
11.7.5 Abbott Recent Development
11.8 AstraZeneca
11.8.1 AstraZeneca Company Details
11.8.2 AstraZeneca Business Overview
11.8.3 AstraZeneca Geriatric Medicine Introduction
11.8.4 AstraZeneca Revenue in Geriatric Medicine Business (2016-2021)
11.8.5 AstraZeneca Recent Development
11.9 Merck
11.9.1 Merck Company Details
11.9.2 Merck Business Overview
11.9.3 Merck Geriatric Medicine Introduction
11.9.4 Merck Revenue in Geriatric Medicine Business (2016-2021)
11.9.5 Merck Recent Development
11.10 Sanofi S.A.
11.10.1 Sanofi S.A. Company Details
11.10.2 Sanofi S.A. Business Overview
11.10.3 Sanofi S.A. Geriatric Medicine Introduction
11.10.4 Sanofi S.A. Revenue in Geriatric Medicine Business (2016-2021)
11.10.5 Sanofi S.A. Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Geriatric Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Analgesics
Table 3. Key Players of Antihypertensives
Table 4. Key Players of Statins
Table 5. Key Players of Antidiabetics
Table 6. Key Players of Proton Pump Inhibitor
Table 7. Key Players of Anticoagulant
Table 8. Key Players of Antipsychotic
Table 9. Key Players of Antidepressant
Table 10. Global Geriatric Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 11. Global Geriatric Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 12. Global Geriatric Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 13. Global Geriatric Medicine Market Share by Regions (2016-2021)
Table 14. Global Geriatric Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 15. Global Geriatric Medicine Market Share by Regions (2022-2027)
Table 16. Geriatric Medicine Market Trends
Table 17. Geriatric Medicine Market Drivers
Table 18. Geriatric Medicine Market Challenges
Table 19. Geriatric Medicine Market Restraints
Table 20. Global Geriatric Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 21. Global Geriatric Medicine Market Share by Players (2016-2021)
Table 22. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicine as of 2020)
Table 23. Ranking of Global Top Geriatric Medicine Companies by Revenue (US$ Million) in 2020
Table 24. Global 5 Largest Players Market Share by Geriatric Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Geriatric Medicine Product Solution and Service
Table 27. Date of Enter into Geriatric Medicine Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 30. Global Geriatric Medicine Revenue Market Share by Type (2016-2021)
Table 31. Global Geriatric Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 32. Global Geriatric Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 33. Global Geriatric Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 34. Global Geriatric Medicine Revenue Market Share by Application (2016-2021)
Table 35. Global Geriatric Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 36. Global Geriatric Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 37. North America Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 38. North America Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 39. North America Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 40. North America Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 41. North America Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 42. North America Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 43. Europe Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 44. Europe Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 45. Europe Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 46. Europe Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 47. Europe Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 48. Europe Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 50. Asia-Pacific Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 52. Asia-Pacific Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 53. Asia-Pacific Geriatric Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 54. Asia-Pacific Geriatric Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 55. Latin America Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 56. Latin America Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 57. Latin America Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 58. Latin America Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 59. Latin America Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 60. Latin America Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Geriatric Medicine Market Size by Type (2016-2021) (US$ Million)
Table 62. Middle East & Africa Geriatric Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Geriatric Medicine Market Size by Application (2016-2021) (US$ Million)
Table 64. Middle East & Africa Geriatric Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 65. Middle East & Africa Geriatric Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 66. Middle East & Africa Geriatric Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 67. GSK Company Details
Table 68. GSK Business Overview
Table 69. GSK Geriatric Medicine Product
Table 70. GSK Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 71. GSK Recent Development
Table 72. Boehringer Ingelheim Company Details
Table 73. Boehringer Ingelheim Business Overview
Table 74. Boehringer Ingelheim Geriatric Medicine Product
Table 75. Boehringer Ingelheim Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 76. Boehringer Ingelheim Recent Development
Table 77. Novartis Company Details
Table 78. Novartis Business Overview
Table 79. Novartis Geriatric Medicine Product
Table 80. Novartis Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 81. Novartis Recent Development
Table 82. Bristol-Myers Squibb Company Details
Table 83. Bristol-Myers Squibb Business Overview
Table 84. Bristol-Myers Squibb Geriatric Medicine Product
Table 85. Bristol-Myers Squibb Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 86. Bristol-Myers Squibb Recent Development
Table 87. Pfizer Company Details
Table 88. Pfizer Business Overview
Table 89. Pfizer Geriatric Medicine Product
Table 90. Pfizer Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 91. Pfizer Recent Development
Table 92. Eli Lilly Company Details
Table 93. Eli Lilly Business Overview
Table 94. Eli Lilly Geriatric Medicine Product
Table 95. Eli Lilly Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 96. Eli Lilly Recent Development
Table 97. Abbott Company Details
Table 98. Abbott Business Overview
Table 99. Abbott Geriatric Medicine Product
Table 100. Abbott Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 101. Abbott Recent Development
Table 102. AstraZeneca Company Details
Table 103. AstraZeneca Business Overview
Table 104. AstraZeneca Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 105. AstraZeneca Recent Development
Table 106. Merck Company Details
Table 107. Merck Business Overview
Table 108. Merck Geriatric Medicine Product
Table 109. Merck Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 110. Merck Recent Development
Table 111. Sanofi S.A. Company Details
Table 112. Sanofi S.A. Business Overview
Table 113. Sanofi S.A. Geriatric Medicine Product
Table 114. Sanofi S.A. Revenue in Geriatric Medicine Business (2016-2021) & (US$ Million)
Table 115. Sanofi S.A. Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Geriatric Medicine Market Share by Type: 2020 VS 2027
Figure 2. Analgesics Features
Figure 3. Antihypertensives Features
Figure 4. Statins Features
Figure 5. Antidiabetics Features
Figure 6. Proton Pump Inhibitor Features
Figure 7. Anticoagulant Features
Figure 8. Antipsychotic Features
Figure 9. Antidepressant Features
Figure 10. Global Geriatric Medicine Market Share by Application: 2020 VS 2027
Figure 11. Cardiovascular Case Studies
Figure 12. Arthritis Case Studies
Figure 13. Neurological Case Studies
Figure 14. Cancer Case Studies
Figure 15. Osteoporosis Case Studies
Figure 16. Respiratory Case Studies
Figure 17. Geriatric Medicine Report Years Considered
Figure 18. Global Geriatric Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 19. Global Geriatric Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 20. Global Geriatric Medicine Market Share by Regions: 2020 VS 2027
Figure 21. Global Geriatric Medicine Market Share by Regions (2022-2027)
Figure 22. Global Geriatric Medicine Market Share by Players in 2020
Figure 23. Global Top Geriatric Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Geriatric Medicine as of 2020
Figure 24. The Top 10 and 5 Players Market Share by Geriatric Medicine Revenue in 2020
Figure 25. Global Geriatric Medicine Revenue Market Share by Type (2016-2021)
Figure 26. Global Geriatric Medicine Revenue Market Share by Type (2022-2027)
Figure 27. North America Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. North America Geriatric Medicine Market Share by Type (2016-2027)
Figure 29. North America Geriatric Medicine Market Share by Application (2016-2027)
Figure 30. North America Geriatric Medicine Market Share by Country (2016-2027)
Figure 31. United States Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Canada Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Europe Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Europe Geriatric Medicine Market Share by Type (2016-2027)
Figure 35. Europe Geriatric Medicine Market Share by Application (2016-2027)
Figure 36. Europe Geriatric Medicine Market Share by Country (2016-2027)
Figure 37. Germany Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. France Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. U.K. Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Italy Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Russia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Nordic Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Asia-Pacific Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Asia-Pacific Geriatric Medicine Market Share by Type (2016-2027)
Figure 45. Asia-Pacific Geriatric Medicine Market Share by Application (2016-2027)
Figure 46. Asia-Pacific Geriatric Medicine Market Share by Region (2016-2027)
Figure 47. China Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Japan Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. South Korea Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Southeast Asia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. India Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Australia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Latin America Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Latin America Geriatric Medicine Market Share by Type (2016-2027)
Figure 55. Latin America Geriatric Medicine Market Share by Application (2016-2027)
Figure 56. Latin America Geriatric Medicine Market Share by Country (2016-2027)
Figure 57. Mexico Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. Brazil Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Middle East & Africa Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. Middle East & Africa Geriatric Medicine Market Share by Type (2016-2027)
Figure 61. Middle East & Africa Geriatric Medicine Market Share by Application (2016-2027)
Figure 62. Middle East & Africa Geriatric Medicine Market Share by Country (2016-2027)
Figure 63. Turkey Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 64. Saudi Arabia Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 65. UAE Geriatric Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 66. GSK Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 67. Boehringer Ingelheim Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 68. Novartis Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 69. Bristol-Myers Squibb Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 70. Pfizer Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 71. Eli Lilly Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 72. Abbott Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 73. AstraZeneca Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 74. Merck Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 75. Sanofi S.A. Revenue Growth Rate in Geriatric Medicine Business (2016-2021)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed

---